Cannabinoid Use in the Treatment of Laryngeal Dystonia and Vocal Tremor: A Pilot Investigation
Read a summary about a study on the use of cannabinoids as a treatment for spasmodic dysphonia, a form of laryngeal dystonia.
Read a summary about a study on the use of cannabinoids as a treatment for spasmodic dysphonia, a form of laryngeal dystonia.
New clinical trial evaluates the safety of DAXXIFY and compares the treatment response to botulinum toxin A in patients with adductor spasmodic dysphonia.
Read a summary from a half-day virtual Research Grantee Workshop held on November 3, 2023
Meeting the New Members Appointed to the Scientific Advisory Board.
Read more about the research projects funded by Dysphonia International in 2023.
Amanda Hu | Northwell Health
Bethany Ho | Hackensack Meridian School of Medicine
Eugenia Castro, MS | USC Voice Center / California State University Los Angeles